Rajni Kant

Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma

Rajni Kant, Chia‐Hung Yen, Chung-Kuang Lu et al. · International Journal of Molecular Sciences · 2016 · 42 citations · Full text

Chemoprevention Strategy, Biochemistry, Glycosylation +15

Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma

Rajni Kant, Chia‐Hung Yen, Jung-Hsien Hung et al. · Scientific Reports · 2019 · 21 citations · Full text

1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice

Rajni Kant, Chung‐Kuang Lu, Hien Minh Nguyen et al. · Biomedicine & Pharmacotherapy · 2020 · 20 citations · Full text

Pathology, Fatty Liver Disease, Insulin Signaling +23

1,2,3,4,6-Penta-O-Galloyl-Beta-D-Glucopyranoside Inhibits Proliferation of Multiple Myeloma Cells Accompanied with Suppression of MYC Expression

Duurenjargal Tseeleesuren, Rajni Kant, Chia‐Hung Yen et al. · Frontiers in Pharmacology · 2018 · 18 citations · Full text

Discovery of an Orally Efficacious MYC Inhibitor for Liver Cancer Using a GNMT-Based High-Throughput Screening System and Structure–Activity Relationship Analysis

Rajni Kant, Ming‐Hui Yang, Chih-Hua Tseng et al. · Journal of Medicinal Chemistry · 2021 · 13 citations